These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17311616)

  • 1. Endocannabinoid receptor CB2 in nonalcoholic fatty liver disease.
    Mendez-Sanchez N; Zamora-Valdes D; Pichardo-Bahena R; Barredo-Prieto B; Ponciano-Rodriguez G; Bermejo-Martínez L; Chavez-Tapia NC; Baptista-González HA; Uribe M
    Liver Int; 2007 Mar; 27(2):215-9. PubMed ID: 17311616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis.
    Wieckowska A; Papouchado BG; Li Z; Lopez R; Zein NN; Feldstein AE
    Am J Gastroenterol; 2008 Jun; 103(6):1372-9. PubMed ID: 18510618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of genes encoding mitochondrial proteins can distinguish nonalcoholic steatosis from steatohepatitis.
    Bragoszewski P; Habior A; Walewska-Zielecka B; Ostrowski J
    Acta Biochim Pol; 2007; 54(2):341-8. PubMed ID: 17502923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic 11beta-HSD1 mRNA expression in fatty liver and nonalcoholic steatohepatitis.
    Konopelska S; Kienitz T; Hughes B; Pirlich M; Bauditz J; Lochs H; Strasburger CJ; Stewart PM; Quinkler M
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):554-60. PubMed ID: 18665910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease.
    Wieckowska A; Zein NN; Yerian LM; Lopez AR; McCullough AJ; Feldstein AE
    Hepatology; 2006 Jul; 44(1):27-33. PubMed ID: 16799979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage migration inhibitory factor expression and MIF gene -173 G/C polymorphism in nonalcoholic fatty liver disease.
    Akyildiz M; Gunsar F; Nart D; Sahin O; Yilmaz F; Akay S; Ersoz G; Karasu Z; Ilter T; Batur Y; Berdeli A; Akarca U
    Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):192-8. PubMed ID: 19829123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and activity of the cytochrome P450 2E1 in patients with nonalcoholic steatosis and steatohepatitis.
    Chtioui H; Semela D; Ledermann M; Zimmermann A; Dufour JF
    Liver Int; 2007 Aug; 27(6):764-71. PubMed ID: 17617119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of Ob-Rb and its relationship with the overexpression of TGF-beta1 and the stage of fibrosis in patients with nonalcoholic steatohepatitis.
    Cayón A; Crespo J; Mayorga M; Guerra A; Pons-Romero F
    Liver Int; 2006 Nov; 26(9):1065-71. PubMed ID: 17032406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic stellate cell activation occurs in nonalcoholic steatohepatitis.
    Cortez-Pinto H; Baptista A; Camilo ME; de Moura MC
    Hepatogastroenterology; 2001; 48(37):87-90. PubMed ID: 11269008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis.
    Nocito A; Dahm F; Jochum W; Jang JH; Georgiev P; Bader M; Renner EL; Clavien PA
    Gastroenterology; 2007 Aug; 133(2):608-18. PubMed ID: 17681180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid CB2 receptors: immunohistochemical localization in rat brain.
    Gong JP; Onaivi ES; Ishiguro H; Liu QR; Tagliaferro PA; Brusco A; Uhl GR
    Brain Res; 2006 Feb; 1071(1):10-23. PubMed ID: 16472786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction.
    Richardson MM; Jonsson JR; Powell EE; Brunt EM; Neuschwander-Tetri BA; Bhathal PS; Dixon JB; Weltman MD; Tilg H; Moschen AR; Purdie DM; Demetris AJ; Clouston AD
    Gastroenterology; 2007 Jul; 133(1):80-90. PubMed ID: 17631134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
    Ito S; Yukawa T; Uetake S; Yamauchi M
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychobiological evidence for the functional presence and expression of cannabinoid CB2 receptors in the brain.
    Onaivi ES
    Neuropsychobiology; 2006; 54(4):231-46. PubMed ID: 17356307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of nonalcoholic steatohepatitis in patients undergoing bariatric surgery: when is liver biopsy indicated?
    Helling TS; Helzberg JH; Nachnani JS; Gurram K
    Surg Obes Relat Dis; 2008; 4(5):612-7. PubMed ID: 18226970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocannabinoid receptors gene expression in morbidly obese women with nonalcoholic fatty liver disease.
    Auguet T; Berlanga A; Guiu-Jurado E; Terra X; Martinez S; Aguilar C; Filiu E; Alibalic A; Sabench F; Hernández M; Del Castillo D; Richart C
    Biomed Res Int; 2014; 2014():502542. PubMed ID: 24864249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid receptors in conjunctival epithelium: identification and functional properties.
    Iribarne M; Torbidoni V; Julián K; Prestifilippo JP; Sinha D; Rettori V; Berra A; Suburo AM
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4535-44. PubMed ID: 18566465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathology of nonalcoholic fatty liver disease.
    Yeh MM; Brunt EM
    Am J Clin Pathol; 2007 Nov; 128(5):837-47. PubMed ID: 17951208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of losartan on early liver fibrosis development in a rat model of nonalcoholic steatohepatitis.
    Ibañez P; Solis N; Pizarro M; Aguayo G; Duarte I; Miquel JF; Accatino L; Arrese M
    J Gastroenterol Hepatol; 2007 Jun; 22(6):846-51. PubMed ID: 17565640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years.
    Furuya CK; de Oliveira CP; de Mello ES; Faintuch J; Raskovski A; Matsuda M; Vezozzo DC; Halpern A; Garrido AB; Alves VA; Carrilho FJ
    J Gastroenterol Hepatol; 2007 Apr; 22(4):510-4. PubMed ID: 17376042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.